ReviewGenes2022

Biomarkers for Monitoring Renal Damage Due to Fabry Disease in Patients Treated with Migalastat: A Review for Nephrologists.

Sebastián Jaurretche et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.